SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-064983
Filing Date
2024-05-24
Accepted
2024-05-24 09:13:37
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2415427d1_defa14a.htm DEFA14A 16655
2 GRAPHIC tm2415427d1_defa14aimg002.jpg GRAPHIC 7710
3 GRAPHIC tm2415427d1_defa14aimg003.jpg GRAPHIC 1402
4 GRAPHIC tm2415427d1_defa14aimg004.jpg GRAPHIC 7484
  Complete submission text file 0001104659-24-064983.txt   41190
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Filer) CIK: 0000884121 (see all company filings)

IRS No.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 811-06565 | Film No.: 24981274